Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Asset Utilization Ratio (2020 - 2022)

Historic Asset Utilization Ratio for Therapeutics (RAPT) over the last 4 years, with Q1 2023 value amounting to 0.0.

  • Therapeutics' Asset Utilization Ratio fell 7942.49% to 0.0 in Q1 2023 from the same period last year, while for Mar 2023 it was 0.0, marking a year-over-year decrease of 7942.49%. This contributed to the annual value of 0.01 for FY2022, which is 7263.78% down from last year.
  • As of Q1 2023, Therapeutics' Asset Utilization Ratio stood at 0.0, which was down 7942.49% from 0.01 recorded in Q4 2022.
  • In the past 5 years, Therapeutics' Asset Utilization Ratio registered a high of 0.05 during Q1 2021, and its lowest value of 0.0 during Q1 2023.
  • Over the past 4 years, Therapeutics' median Asset Utilization Ratio value was 0.02 (recorded in 2021), while the average stood at 0.02.
  • In the last 5 years, Therapeutics' Asset Utilization Ratio tumbled by 4555.51% in 2022 and then tumbled by 7942.49% in 2023.
  • Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.04 in 2020, then tumbled by 54.94% to 0.02 in 2021, then crashed by 64.97% to 0.01 in 2022, then tumbled by 46.36% to 0.0 in 2023.
  • Its Asset Utilization Ratio stands at 0.0 for Q1 2023, versus 0.01 for Q4 2022 and 0.01 for Q3 2022.